Answers are grounded in this paper and cite their sources.
One hundred forty consecutive cancer patients had percutaneously placed subclavian vein catheters for up to 882 days' duration. The incidence of suspected and proven catheter-related sepsis was low. This is a cost-effective alternative to tunneled catheter insertion for chronic venous access in cancer patients.
No takes yet. Share an insight, caveat, or question.
Slater et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: